Abstract:Natural products, and their derivatives and mimics, have contributed to the development of important therapeutics to combat diseases such as infections and cancers over the past decades. The value of natural products to modern drug discovery is still considerable. However, its development is hampered by a lack of a mechanistic understanding of their molecular action, as opposed to the emerging molecule-targeted therapeutics that are tailored to a specific protein target(s). Recent advances in the mass spectrometry-based proteomic approaches have the potential to offer unprecedented insights into the molecular action of natural products. Chemical proteomics is established as an invaluable tool for the identification of protein targets of natural products. Small-molecule affinity selection combined with mass spectrometry is a successful strategy to "fish" cellular targets from the entire proteome. Mass spectrometry-based profiling of protein expression is also routinely employed to elucidate molecular pathways involved in the therapeutic and possible toxicological responses upon treatment with natural products. In addition, mass spectrometry is increasingly utilized to probe structural aspects of natural products-protein interactions. Limited proteolysis, photoaffinity labeling, and hydrogen/deuterium exchange in conjunction with mass spectrometry are sensitive and high-throughput strategies that provide low-resolution structural information of non-covalent natural product-protein complexes. In this review, we provide an overview on the applications of mass spectrometry-based techniques in the identification and characterization of natural product-protein interactions, and we describe how these applications might revolutionize natural product-based drug discovery.

Mass spectrometry-based methods for investigating the dynamics and organization of the surfaceome: exploring potential clinical implications

Cell surface glycoproteomics: deciphering glycoproteins through a unique analytical capture approach

Characterization of Cell Surface Glycoproteins Using Enzymatic Treatment and Mass Spectrometry

Recent progress in mass spectrometry proteomics for biomedical research

Mass Spectrometry of Protein Complexes: From Origins to Applications

Mass Spectrometry Methods for In Situ Analysis of Clinical Biomolecules

Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins

Mass spectrometry-based structure-specific N- glycoproteomics and biomedical applications

Recent Advances in Mass Spectrometry-based Protein Interactome Studies

Advancements in mass spectrometry-based glycoproteomics and glycomics

Ultrafast and Chemoselective Biotinylation of Living Cell Surfaces for Time-Resolved Surfaceome Analysis

Developments and Ongoing Challenges for Analysis of Surface-Bound Proteins

Molecular Modification and Assembly at Cell Surface for Biochemical Analysis

Mass spectrometry-based metabolomics, analysis of metabolite-protein interactions, and imaging

Identification and characterization of molecular targets of natural products by mass spectrometry.

Surface-enhanced Raman scattering sensing for detection and mapping of key cellular biomarkers

Cell Surface Protein–protein Interaction Profiling for Biological Network Analysis and Novel Target Discovery

Hybrid methods of surface plasmon resonance coupled to mass spectrometry for biomolecular interaction analysis

Emerging mass spectrometry-based proteomics methodologies for novel biomedical applications

Mass spectrometry for translational proteomics: progress and clinical implications

Recent Progress On The Applications Of Mass Spectrometry And Related Techniques To The Signal Transduction